Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-Mesitran vs Fluconazole for Recurrent Vulvovaginal Candidiasis
NCT04626258Phase 4Unknown
- Sponsor
- Maastricht University Medical Center+
- Start
- Mar 2021
- Primary completion
- Mar 2024
01
Overview
A Phase 4 trial of Revamil in recurrent vulvovaginal candidiasis (RVVC), sponsored by Maastricht University Medical Center+. Status: unknown.
02
Drugs
Revamil
03
Conditions
recurrent vulvovaginal candidiasis (RVVC)
Beyond the preview
Go deeper on NCT04626258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04626258.